Additionally, vaccination with the MVAmesoA35Del virus induced 52% more responding T lymphocytes compared to the MVAmeso virus, suggesting that removal of the A35 induced a stronger immune response, but the difference did not reach statistical significance.
← all excerpts
Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.
1
—
—